Abstract
Gap junction channel selectivity, open probability, and recruitment are properties that affect the transit of solutes from cell to cell. Selectivity is the property of an open channel that acts as a discriminator, allowing the passage of specific solutes while denying transit to others. Open probability is another parameter that can affect the efficiency of cell to cell transit. Channel recruitment is another facilitating mechanism able to affect transit. Rapid alterations in any of these properties suggests that dynamic effects are possible for gap junction channel mediated cell to cell coupling. Suspect modulators presumably capable of effecting dynamic change would be the kinases. The properties of gap junction channels in the context of selectivity, open probability and recruitment are discussed here along with the ability of kinases to affect them. These processes and their regulation are also targets for regulating cell-to-cell communication through therapeutics. Clearly these same properties are ones that disease states might also opportunistically alter to affect physiological processes.
Current Drug Targets
Title: Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?
Volume: 3 Issue: 6
Author(s): Peter R. Brink
Affiliation:
Abstract: Gap junction channel selectivity, open probability, and recruitment are properties that affect the transit of solutes from cell to cell. Selectivity is the property of an open channel that acts as a discriminator, allowing the passage of specific solutes while denying transit to others. Open probability is another parameter that can affect the efficiency of cell to cell transit. Channel recruitment is another facilitating mechanism able to affect transit. Rapid alterations in any of these properties suggests that dynamic effects are possible for gap junction channel mediated cell to cell coupling. Suspect modulators presumably capable of effecting dynamic change would be the kinases. The properties of gap junction channels in the context of selectivity, open probability and recruitment are discussed here along with the ability of kinases to affect them. These processes and their regulation are also targets for regulating cell-to-cell communication through therapeutics. Clearly these same properties are ones that disease states might also opportunistically alter to affect physiological processes.
Export Options
About this article
Cite this article as:
Peter R. Brink , Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?, Current Drug Targets 2002; 3 (6) . https://dx.doi.org/10.2174/1389450023347326
DOI https://dx.doi.org/10.2174/1389450023347326 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effects of Medications Used for the Management of Diabetes and Obesity on Postprandial Lipid Metabolism
Current Diabetes Reviews Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
Current Neuropharmacology Potential of Antibiotics for the Treatment and Management of Parkinson's Disease: An Overview
Current Drug Research Reviews NSAIDs Induced Regulation of Alternatively Spliced Transcript Isoforms: Possible Role in Cancer and Alzheimer Disease
Current Cancer Drug Targets Gabapentin-Mediated Effects on Voltage- and Ligand-Gated Currents
Current Neuropharmacology Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Current Gene Therapy Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Current Topics in Medicinal Chemistry On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design Methylation Profile of miR-9-1 and miR-9-1/-9-3 as Potential Biomarkers of Diabetic Retinopathy
Current Diabetes Reviews High Prevalence of Vitamin D Deficiency and Correlation with Cystatin-C and Other Cardiovascular and Renal Risk Biomarkers in Patients with Type 2 Diabetes Mellitus Complicated with Hypertension
Current Diabetes Reviews Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes
Current Enzyme Inhibition Meet Our Editorial Board Member
Current Neuropharmacology GABAergic Pharmacotherapy in the Treatment of Motor Disorders of the Central Nervous System
Current Pharmaceutical Design Structures Required of Flavonoids for Inhibiting Digestive Enzymes
Anti-Cancer Agents in Medicinal Chemistry Gene Therapy for Parkinsons and Alzheimers Diseases: from the Bench to Clinical Trials
Current Pharmaceutical Design Gastrointestinal Immune System and Brain Dialogue Implicated in Neuroinflammatory and Neurodegenerative Diseases
Current Molecular Medicine Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview
CNS & Neurological Disorders - Drug Targets GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies
CNS & Neurological Disorders - Drug Targets Application of Sulfamic Acid in Organic Synthesis-A Short Review
Current Organic Chemistry Antidepressant Administration Modulates Neural Stem Cell Survival and Serotoninergic Differentiation Through Bcl-2
Current Neurovascular Research